Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Hansen

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2005
Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicitiesRyan J Hansen, Ramamoorthy Nagasubramanian, Shannon M Delaney, et al.
British Journal of Clinical Pharmacology|December 10, 2015
Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosusJennifer Witcher, Roy Fleischmann, Vishala L Chindalore, et al.
Mutagenesis|May 15, 2008
Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposureRamamoorthy Nagasubramanian, Ryan J Hansen, Shannon M Delaney, et al.
American Journal of Veterinary Research|June 27, 2017
Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamideKatherine A Stroda, Jacqueline D Murphy, Ryan J Hansen, et al.
Mabs|December 17, 2016
Quantitative characterization of the mechanism of action and impact of a 'proteolysis-permitting' anti-PCSK9 antibodyRyan J Hansen, Michael J Berna, Andrea E Sperry, et al.
Nanoscale|September 24, 2013
Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine modelO Andrea Wong, Ryan J Hansen, Thomas W Ni, et al.
Journal of the American Chemical Society|November 6, 2015
Substituent Effects in CH Hydrogen Bond Interactions: Linear Free Energy Relationships and Influence of AnionsBlakely W Tresca, Ryan J Hansen, Calvin V Chau, et al.
American Journal of Veterinary Research|November 27, 2012
Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasRachel O Venable, Deanna R Worley, Daniel L Gustafson, et al.
Journal of Lipid Research|September 23, 2015
Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibodyKrista M Schroeder, Thomas P Beyer, Ryan J Hansen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2013
Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's diseaseBriana R De Miranda, James A Miller, Ryan J Hansen, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2005
Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicitiesRyan J Hansen, Ramamoorthy Nagasubramanian, Shannon M Delaney, et al.
British Journal of Clinical Pharmacology|December 10, 2015
Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosusJennifer Witcher, Roy Fleischmann, Vishala L Chindalore, et al.
Mutagenesis|May 15, 2008
Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposureRamamoorthy Nagasubramanian, Ryan J Hansen, Shannon M Delaney, et al.
American Journal of Veterinary Research|June 27, 2017
Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamideKatherine A Stroda, Jacqueline D Murphy, Ryan J Hansen, et al.
Mabs|December 17, 2016
Quantitative characterization of the mechanism of action and impact of a 'proteolysis-permitting' anti-PCSK9 antibodyRyan J Hansen, Michael J Berna, Andrea E Sperry, et al.
Nanoscale|September 24, 2013
Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine modelO Andrea Wong, Ryan J Hansen, Thomas W Ni, et al.
Journal of the American Chemical Society|November 6, 2015
Substituent Effects in CH Hydrogen Bond Interactions: Linear Free Energy Relationships and Influence of AnionsBlakely W Tresca, Ryan J Hansen, Calvin V Chau, et al.
American Journal of Veterinary Research|November 27, 2012
Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasRachel O Venable, Deanna R Worley, Daniel L Gustafson, et al.
Journal of Lipid Research|September 23, 2015
Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibodyKrista M Schroeder, Thomas P Beyer, Ryan J Hansen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2013
Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's diseaseBriana R De Miranda, James A Miller, Ryan J Hansen, et al.
Pageof 5